查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375481

生物製药生物分离系统市场：按类型、最终用户划分 - 全球预测 2023-2030 年

Biopharmaceutical Bioseparation Systems Market by Type (Cell Disruption Technology, Centrifuges Technology, Chromatography Technique), End-user (Biopharmaceutical Companies, Research Institutes) - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

生物製药生物分离系统市场预计将从 2022 年的 138.5 亿美元增加到 2030 年的 284.9 亿美元，预测期内年复合成长率为 9.42%。

生物製药生物分离系统的全球市场

主要市场统计
市场金额：基准年 [2022] 138.5亿美元
预计市场价值 [2023] 151亿美元
预计市场量[2030] 284.9亿美元
年复合成长率（%） 9.42%
生物製药生物分离系统市场-IMG1

FPNV定位矩阵

FPNV定位矩阵是评估生物製药生物分离系统市场的重要工具。透过分析与业务策略和产品满意度相关的关键指标来全面评估供应商。这使得使用者能够根据自己的具体资讯做出明智的决策。进阶分析将供应商分为四个像限，每个象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。这个富有洞察力的框架使决策者能够充满信心地驾驭市场。

市场占有率分析

市场占有率分析为供应商的市场形势提供了宝贵的见解。评估对整体收益、客户群和其他关键指标的影响可以全面了解公司的业绩及其面临的竞争环境。该分析还揭示了研究期间的竞争水平，例如市场占有率增长、碎片化、主导地位和行业整合。

该报告对以下几个方面提供了宝贵的见解：

1.市场渗透：提供有关市场动态和主要企业产品的全面资讯。

2. 市场开拓：详细分析新兴和成熟细分市场的渗透情况，以突显利润丰厚的商机。

3. 市场多元化：有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

5. 产品开发与创新：对未来技术、研发活动和突破性产品开发的智慧洞察。

本报告解决了以下关键问题：

1.生物製药生物分离系统市场的市场规模与预测为何？

2. 生物製药生物分离系统市场中哪些产品、细分市场、应用和领域具有最高投资潜力？

3.生物製药生物分离系统市场的竞争策略视窗有哪些？

4.生物製药生物分离系统市场的最新技术趋势和法律规范是什么？

5.生物製药生物分离系统市场主要供应商的市场占有率是多少？

6. 进入生物製药生物分离系统市场的合适型态和策略性手段是什么？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 对生物製药和个人化医疗的需求不断增长
      • 政府支持国内医药产业的配合措施
      • 标靶治疗的日益普及和重要性
    • 抑制因素
      • 生物分离设备初期投资运作成本较高
    • 机会
      • 扩大对生物分离公司和技术的投资
      • 生物製药分离技术的进展
    • 任务
      • 法规挑战和复杂的检验流程
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第6章生物製药生物分离系统市场：依类型

  • 细胞破坏技术
  • 离心机技术
  • 色谱技术
  • 电泳
  • 萃取技术
  • 过滤技术
  • 基于膜的
  • 沉淀

第7章生物製药生物分离系统市场：依最终用户分类

  • 生物製药公司
  • 调查机构

第8章美洲生物製药生物分离系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第9章亚太地区生物製药生物分离系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲生物製药生物分离系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第11章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 竞争情境分析：主要企业

第12章竞争产品组合

  • 主要企业简介
    • 3M Company
    • Agilent Technologies, Inc.
    • Alfa Wassermann, Inc.
    • Asahi Kasei Medical Co., Ltd.
    • Astrea Bioseparations Limited
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Flottweg SE
    • GEA Group Aktiengesellschaft
    • GL Sciences Inc.
    • Hitachi High-Tech Corporation.
    • Jasco Pty Ltd.
    • KNAUER Wissenschaftliche Gerate GmbH
    • Merck KGaA
    • Novasep Holding SAS
    • PerkinElmer Inc.
    • Repligen Corporation
    • Restek Corporation
    • Sartorius AG
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Tosoh Bioscience LLC
    • Waters Corporation
    • YMC Co., Ltd.
  • 主要产品系列

第13章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-521BAA36EA9C

The Biopharmaceutical Bioseparation Systems Market is projected to reach USD 28.49 billion by 2030 from USD 13.85 billion in 2022, at a CAGR of 9.42% during the forecast period.

Global Biopharmaceutical Bioseparation Systems Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 13.85 billion
Estimated Year Value [2023] USD 15.10 billion
Forecast Year Value [2030] USD 28.49 billion
CAGR (%) 9.42%
Biopharmaceutical Bioseparation Systems Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Biopharmaceutical Bioseparation Systems Market.

Based on Type, market is studied across Cell Disruption Technology, Centrifuges Technology, Chromatography Technique, Electrophoresis, Extraction Technique, Filtration Technology, Membrane-based, and Precipitation. The Electrophoresis is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Biopharmaceutical Companies and Research Institutes. The Biopharmaceutical Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Biopharmaceutical Bioseparation Systems Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Biopharmaceutical Bioseparation Systems Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Biopharmaceutical Bioseparation Systems Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Agilent Technologies, Inc., Alfa Wassermann, Inc., Asahi Kasei Medical Co., Ltd., Astrea Bioseparations Limited, Bio-Rad Laboratories, Inc., Danaher Corporation, Flottweg SE, GEA Group Aktiengesellschaft, GL Sciences Inc., Hitachi High-Tech Corporation., Jasco Pty Ltd., KNAUER Wissenschaftliche Gerate GmbH, Merck KGaA, Novasep Holding SAS, PerkinElmer Inc., Repligen Corporation, Restek Corporation, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Bioscience LLC, Waters Corporation, and YMC Co., Ltd..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Biopharmaceutical Bioseparation Systems Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Biopharmaceutical Bioseparation Systems Market?

3. What is the competitive strategic window for identifying opportunities in the Biopharmaceutical Bioseparation Systems Market?

4. What are the latest technology trends and regulatory frameworks in the Biopharmaceutical Bioseparation Systems Market?

5. What is the market share of the leading vendors in the Biopharmaceutical Bioseparation Systems Market?

6. Which modes and strategic moves are suitable for entering the Biopharmaceutical Bioseparation Systems Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biopharmaceutical Bioseparation Systems Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for biopharmaceuticals and personalized medicines
      • 5.1.1.2. Government initiatives to boost domestic pharmaceutical industry
      • 5.1.1.3. Growing popularity and importance of targeted therapies
    • 5.1.2. Restraints
      • 5.1.2.1. High initial investments and operating costs of bioseparation equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing investments in bioseparation companies and technologies
      • 5.1.3.2. Rising advancements in biopharmaceutical separation technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory challenges and complex validation processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Biopharmaceutical Bioseparation Systems Market, by Type

  • 6.1. Introduction
  • 6.2. Cell Disruption Technology
  • 6.3. Centrifuges Technology
  • 6.4. Chromatography Technique
  • 6.5. Electrophoresis
  • 6.6. Extraction Technique
  • 6.7. Filtration Technology
  • 6.8. Membrane-based
  • 6.9. Precipitation

7. Biopharmaceutical Bioseparation Systems Market, by End-user

  • 7.1. Introduction
  • 7.2. Biopharmaceutical Companies
  • 7.3. Research Institutes

8. Americas Biopharmaceutical Bioseparation Systems Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biopharmaceutical Bioseparation Systems Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biopharmaceutical Bioseparation Systems Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. 3M Company
    • 12.1.2. Agilent Technologies, Inc.
    • 12.1.3. Alfa Wassermann, Inc.
    • 12.1.4. Asahi Kasei Medical Co., Ltd.
    • 12.1.5. Astrea Bioseparations Limited
    • 12.1.6. Bio-Rad Laboratories, Inc.
    • 12.1.7. Danaher Corporation
    • 12.1.8. Flottweg SE
    • 12.1.9. GEA Group Aktiengesellschaft
    • 12.1.10. GL Sciences Inc.
    • 12.1.11. Hitachi High-Tech Corporation.
    • 12.1.12. Jasco Pty Ltd.
    • 12.1.13. KNAUER Wissenschaftliche Gerate GmbH
    • 12.1.14. Merck KGaA
    • 12.1.15. Novasep Holding SAS
    • 12.1.16. PerkinElmer Inc.
    • 12.1.17. Repligen Corporation
    • 12.1.18. Restek Corporation
    • 12.1.19. Sartorius AG
    • 12.1.20. Shimadzu Corporation
    • 12.1.21. Thermo Fisher Scientific Inc.
    • 12.1.22. Tosoh Bioscience LLC
    • 12.1.23. Waters Corporation
    • 12.1.24. YMC Co., Ltd.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET DYNAMICS
  • FIGURE 7. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 8. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 10. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 12. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 14. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 20. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CELL DISRUPTION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGES TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY EXTRACTION TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY FILTRATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 104. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 105. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET LICENSE & PRICING